CMS certification 260141
University of Missouri Health Care
One Hospital Drive, Columbia, MO 65212
University of Missouri Health Care has a CMS overall rating of 3 out of 5 stars. 71% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 2 and worse on 3. Emergency patients spend a median of 3 h 42 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 1,680 completed surveys, 27% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | MO | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 412 visits sampled · US median for EDs of the same volume: 3 h 21 min | 3 h 42 min | 2 h 35 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 21 visits sampled | 3 h 2 min | 4 h 23 min | 4 h 17 min |
| Left before being seen Lower is better · 137,401 patients | 2% | 3% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 159 patients | 39% | 63% | 65% |
How University of Missouri Health Care compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| University of Missouri Health CareThis hospital | 3/5 | 71% | 3 h 42 min | 2 better 3 worse |
| Boone Hospital CenterSame city | 4/5 | 78% | 2 h 55 min | 4 better 2 worse |
| Columbia Mo VA Medical CenterSame city | 4/5 | 86% | — | 3 worse |
| Moberly Regional Medical CenterSame ZIP area · Moberly | 2/5 | 64% | 1 h 54 min | No different |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Columbia.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 5,480 cases | Too few cases | 4.7% | 3.9% |
| Heart attack 195 cases | Too few cases | 11.3% | 11.9% |
| Heart failure 400 cases | Too few cases | 13.2% | 11.1% |
| Pneumonia 482 cases | Too few cases | 13.3% | 15.2% |
| Stroke 608 cases | Too few cases | 12.4% | 11.9% |
| COPD 268 cases | Too few cases | 9.7% | 8.6% |
| Heart bypass surgery (CABG) 57 cases | Too few cases | 3.6% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.79 likely 0.55 – 1.04 | 1 |
| After hip or knee replacement 102 cases | Too few cases | 6.4% | 4.1% |
| Deaths after a serious but treatable surgical complication 170 cases | No different | 162.66 per 1,000 likely 121.19 per 1,000 – 204.12 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 7,975 cases | Better | 0.09 per 1,000 likely 0 per 1,000 – 0.62 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 9,221 cases | No different | 0.15 per 1,000 likely 0 per 1,000 – 0.34 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 9,477 cases | No different | 0.29 per 1,000 likely 0.1 per 1,000 – 0.47 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 2,879 cases | No different | 1.86 per 1,000 likely 0.63 per 1,000 – 3.1 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,536 cases | No different | 1.05 per 1,000 likely 0 per 1,000 – 2.42 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,388 cases | No different | 7.7 per 1,000 likely 2.81 per 1,000 – 12.59 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 3,043 cases | Worse | 5.55 per 1,000 likely 3.91 per 1,000 – 7.19 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,448 cases | No different | 3.59 per 1,000 likely 0.7 per 1,000 – 6.48 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 594 cases | No different | 1.66 per 1,000 likely 0.3 per 1,000 – 3.01 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,928 cases | No different | 1.23 per 1,000 likely 0.36 per 1,000 – 2.1 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.47 likely 0.27 – 0.77 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.43 likely 0.26 – 0.68 | 1 |
| Surgical site infections after colon surgery | No different | 0.77 likely 0.39 – 1.36 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 0.67 likely 0.11 – 2.22 | 1 |
| MRSA bloodstream infections | No different | 0.76 likely 0.42 – 1.27 | 1 |
| C. diff intestinal infections | Better | 0.41 likely 0.31 – 0.54 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 344 cases | Too few cases | 14.4% | 14.4% |
| Readmitted after heart failure 786 cases | Too few cases | 22.4% | 21.3% |
| Readmitted after pneumonia 844 cases | Too few cases | 16.8% | 17.3% |
| Readmitted after COPD 575 cases | Too few cases | 21.2% | 20% |
| Readmitted after heart bypass surgery 65 cases | Too few cases | 11.7% | 11% |
| Readmitted after hip or knee replacement 103 cases | Too few cases | 5.6% | 5.8% |
| Days back in hospital after a heart attack 233 cases | Too few cases | 11.5 days per 100 | — |
| Days back in hospital after heart failure 447 cases | Too few cases | 28.4 days per 100 | — |
| Days back in hospital after pneumonia 518 cases | Too few cases | -5.7 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 1,042 cases | No different | 13.3 per 1,000 likely 10.2 per 1,000 – 17.3 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 438 cases | No different | 11.7 per 100 likely 9.5 per 100 – 14.3 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 438 cases | No different | 5.5 per 100 likely 4.1 per 100 – 7.3 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 1,629 cases | No different | 0.8 likely 0.7 – 1 | — |
1 more measure had too few cases here to report.
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $9.8M
- 2020 $6.9M
- 2021 $11.5M
- 2022 $10M
- 2023 $11M
- 2024 $67.4M
- 2025 $70.8M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Speaking, teaching and other services | $64.4M | 336 |
| Grants | $544,015 | 27 |
| Space rental and facility fees | $155,682 | 70 |
| Education | $12,387 | 4 |
| Debt forgiveness | $8,388 | 7 |
| Medical devices and supplies on long-term loan | $6,910 | 1 |
| Charitable contributions | $5,150 | 1 |
| Royalties and licensing fees | $3,000 | 1 |
| Consulting fees | $2,912 | 2 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Advanced Accelerator Applications | $64.3M | 331 |
| Synthes USA Products LLC | $3.6M | 2 |
| Elite Orthopedics, LLC | $324,882 | 1 |
| AstraZeneca Pharmaceuticals LP | $282,936 | 10 |
| Janssen Research & Development, LLC | $249,372 | 37 |
| Merz Pharmaceuticals, LLC | $127,512 | 5 |
| Abbvie INC. | $125,297 | 20 |
| Eli Lilly and Company | $113,265 | 4 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| Prevention of Proximal Femoral Fracture with Prophylactic Calcar Screw Fixation in Distal Femur Fracture: A Biomechanical Study Synthes USA Products LLC | $3.6M |
| A Phase III, Open-label, Randomised Study of Neoadjuvant Datopotamab Deruxtecan (Dato DXd) Plus Durvalumab Followed by Adjuvant Durvalumab With or Wi… AstraZeneca Pharmaceuticals LP | $154,233 |
| Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of NT 201 in the Treatment of Low… Merz Pharmaceuticals, LLC | $127,512 |
| ACCELERATE a Multisite Prospective Hybrid (Effectiveness-implementation) Type 2 Design, Single-arm, Mixed-methods Study of a Simplified Accelerated A… Gilead Sciences, Inc. | $101,000 |
| EMBER-4: A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ADJUVANT IMLUNESTRANT VS STANDARD ADJUVANT ENDOCRINE THERAPY IN PATIENTS WHO HAVE PREVIOUSLY RECE… Eli Lilly and Company · NCT05514054 | $93,835 |
| A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis VERTEX PHARMACEUTICALS INCORPORATED | $82,500 |
| A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral … Janssen Research & Development, LLC | $66,631 |
| A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Sel… Janssen Research & Development, LLC | $60,996 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about University of Missouri Health Care
Is University of Missouri Health Care a good hospital?
University of Missouri Health Care has a CMS overall rating of 3 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 2 and worse on 3. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend University of Missouri Health Care?
71% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 1,680 completed HCAHPS surveys.
How long is the wait in the University of Missouri Health Care emergency room?
Emergency patients spend a median of 3 h 42 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 2% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does University of Missouri Health Care receive money from drug and device companies?
Drug and device makers reported $70.8M in payments to University of Missouri Health Care for 2025, under the federal Open Payments program. A payment on its own does not show a conflict of interest.